Xiaohong Ma
-
- Cancer, Lipids, and Metabolism 5
- Cancer-related molecular mechanisms research 3
- MicroRNA in disease regulation 2
-
- Endometrial and Cervical Cancer Treatments 2
-
- Epigenetics and DNA Methylation 2
-
- Ferroptosis and cancer prognosis 3
-
- Radiomics and Machine Learning in Medical Imaging 2
-
- Bladder and Urothelial Cancer Treatments 2
- Journals
- Cell Death and Disease (3 papers)Cell Death Discovery (1 paper)British Journal of Cancer (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Xiaohong Ma
17 papers receiving 301 citations
Peers
Comparison fields: 5 of 66
- Cancer Research 105
- Obstetrics and Gynecology 29
- Oncology 84
- Immunology 50
- Molecular Biology 161
Countries citing papers authored by Xiaohong Ma
This map shows the geographic impact of Xiaohong Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohong Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohong Ma more than expected).
Fields of papers citing papers by Xiaohong Ma
This network shows the impact of papers produced by Xiaohong Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohong Ma. The network helps show where Xiaohong Ma may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaohong Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 7 | |
| 9 | 2023 | 18 | |
| 10 | 2023 | 4 | |
| 11 | 2022 | 8 | |
| 12 | 2022 | 6 | |
| 13 | 2022 | 20 | |
| 14 | 2021 | 42 | |
| 15 | 2021 | 9 | |
| 16 | 2021 | 1 | |
| 17 | 2021 | 16 | |
| 18 | 2020 | 25 | |
| 19 | 2019 | 16 | |
| 20 | 2019 | 33 |
About Xiaohong Ma
Xiaohong Ma is a scholar working on Cancer Research, Obstetrics and Gynecology and Cell Biology, having authored 22 papers that have together received 305 indexed citations. Recurring topics across this work include Cancer, Lipids, and Metabolism (5 papers), Ferroptosis and cancer prognosis (3 papers), Cancer-related molecular mechanisms research (3 papers), Radiomics and Machine Learning in Medical Imaging (2 papers), Bladder and Urothelial Cancer Treatments (2 papers), Endometrial and Cervical Cancer Treatments (2 papers), Epigenetics and DNA Methylation (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Cancer Research (105 citations), Obstetrics and Gynecology (29 citations) and Oncology (84 citations). Xiaohong Ma has collaborated with scholars based in China and United States. Frequent co-authors include Jie Jiang, Zhiming Liu, Chunping Qiu, Lina Wei, Tianyi Zhao, Wenzhi Li, Yixin Hou, Zhe Wang, Shanshan Xiong and Xueliang Zhou. Their work appears in journals such as Cell Death and Disease, Cell Death Discovery, British Journal of Cancer, Scientific Reports and Academic Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.